VEGFA and hepatocellular carcinoma: HCC cells produce cytokines, such as VEGF, GM-CSF, and IL-1β, to attract MDSCs, and treatments targeting MDSCs might increase the sensitivity of immune checkpoint inhibitors (ICIs) promoting the antitumor response (87).